NEW YORK–(BUSINESS WIRE)– Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, announced today the appointment of Eric Luthi as Chief Business Officer. In this newly created role, Mr. Luthibrings...
Read More
New York, NY – March 4, 2024 – Koneksa, the evidence-based digital biomarkers company, today announced the appointment of Jessie Bakker, M.S., Ph.D., as Vice President (VP) of Clinical Development....
Read More
NEW YORK–(BUSINESS WIRE)–Koneksa, the evidence-based digital biomarkers company, today announced the appointment of Dave Hurry as Chief Data Officer and Larsson Omberg, Ph.D., as Executive Vice President of Data Science....
Read More
Hirschfeld to Join as Koneksa an Independent Director NEW YORK, April 23, 2019 /PRNewswire/ — Koneksa Health, a private company that enables the biopharmaceutical industry to develop new medicines using innovative solutions...
Read More
Renowned oncologist William A. Wood, MD, MPH, of UNC Lineberger joins scientific advisors NEW YORK, Jan. 8, 2019 /PRNewswire/ — Koneksa Health, a private company that enables the biopharmaceutical...
Read More
